New Product Newswire

News
Article

Omacor, (omega-3 acid ethyl esters) will be marketed in the United States by Reliant Pharmaceuticals, Liberty Corner, N.J., (908) 580-1200.

Related Content
FDA Approves GSK's BLA for 5-in-1 Meningococcal Vaccine

FDA Approves GSK's BLA for 5-in-1 Meningococcal Vaccine

April 16th 2024
Article

The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.

Over the Counter podcast

Episode 8: Stay in Sync with Innovations in Medication Decision Support

August 6th 2020
Podcast

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma

FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma

April 12th 2024
Article

Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.

FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications

FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications

April 4th 2024
Article

The antibiotic was approved to treat Staphylococcus aureas bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.

FDA Approves Iloperidone for Acute Treatment of Manic, Mixed Episodes in Bipolar I

FDA Approves Iloperidone for Acute Treatment of Manic, Mixed Episodes in Bipolar I

April 4th 2024
Article

The drug was previously approved in 2009 to treat schizophrenia.

FDA Clears First Digital Therapeutic to Treat Major Depressive Disorder

FDA Clears First Digital Therapeutic to Treat Major Depressive Disorder

April 2nd 2024
Article

Rejoyn from Otsuka Pharmaceutical and Click Therapeutics is a 6-week program that helps enhance cognitive control of emotions through brief therapy lessons and training exercises.

© 2024 MJH Life Sciences

All rights reserved.